TP53 and Miyoshi myopathy: Differential spontaneous somatic mutation profiling in CA versus AA MM cases has revealed that the most striking and statistically significant difference between the two groups lies in the prevalence of somatic mutation in the TP53 tumor suppressor gene [11].